Abstract:Background/Purpose Genome-Wide Association Studies (GWAS) have unveiled over 1000 risk variants for lupus, predominantly situated in non-coding genomic regions. Their functional roles, especially their potential impacts on the dysregulated type I interferon pathway inherent in lupus, remain largely uncharted. To bridge this knowledge gap, our study employs CRISPR/Cas9 technology, enabling a deeper exploration into the functional implications of these risk loci. Methods Our novel strategy entailed CRISPR-based screening for functional variants that regulate the type I interferon pathway. We collected all known SLE-associated SNPs and expanded them through linkage disequilibrium in the population where the SNP was reported. We designed an sgRNA library covering these SLE-associated SNPs and developed a cellular model using U-937, Jurkat, and Raji cells that stably express the CRISPR/Cas9-ISRE-GFP and CRISPR/SAM-ISRE-GFP systems. Post-transduction with the sgRNA lentiviral library, we sorted cells based on GFP intensity and extracted and sequenced DNA from these sorted cells. The functional variants were identified and characterized using multi-omics analysis (eQTL data, HiC data, RNA-sequencing data). We validated the function of the rs11152966-located region and identified PRDM1 as the target gene of rs11152966 through integration of advanced technologies like capture-HiC, CRISPR-SAM, and prime editing technology. Results We've characterized the comprehensive landscape of functional SNPs related to lupus that regulate the Type I interferon pathway (figure 1). Notably, we discovered that the majority of these functional variant regions are cell type-specific (figure 1). Utilizing the CRISPR/Cas9 and CRISPR/SAM systems effectively, we found these tools to have complementary benefits in the identification of these functional variants. Furthermore, these functional variant regions were found to be associated with the expression of critical regulators within the JAK-STAT pathway and interferon-stimulated genes (ISGs) (figure 2). Importantly, we observed a correlation between the expression of transcription factors disrupted by these functional variants and the expression of ISGs in SLE patients (figure 2). One standout finding was the negative regulatory effect on the Type I interferon pathway upon activation of the region containing the SNP rs11152966 (figure 3). This region, inclusive of the SNP, forms a gene loop with the PRDM1 promoter, thereby managing PRDM1 expression (figure 3). Additionally, we provided evidence that PRDM1 acts as a novel negative regulator of the Type I interferon pathway (figure 3). Lastly, our research revealed a link between the presence of the risk allele T and a reduction in PRDM1 expression. This reduced expression appears to be due to the allele T's effect on the binding of the transcription factor SPI1 (figure 3). Conclusion Our study leveraged advanced gene-editing tools to elucidate the landscape of functional SNPs in lupus, revealing their cell type-specific regulation of the Type I interferon pathway and their influence on key genes in the JAK-STAT pathway. Notably, we highlighted the significant role of SNP rs11152966 and its target gene PRDM1 in regulating the interferon pathway in lupus.

Transcriptional Regulation of CD40 Expression by 4 Ribosomal Proteins via a Functional SNP on a Disease-Associated CD40 Locus

Association of Polymorphisms in the IL‐10 Promoter Region with Crohn's Disease

Post-GWAS functional studies reveal an RA-associated CD40 -induced NF-kB signal transduction and transcriptional regulation network targeted by class II HDAC inhibitors

Effect of CD40-P227A Polymorphism at Human B Cell Signaling Pathways

CD40/TRAF1 Decreases Synovial Cell Apoptosis in Patients with Rheumatoid Arthritis Through JNK/NF-κB Pathway.

CD40/TNF receptor associated factor 1 expression and NF-κB-dependent proinflammatory gene expression in rheumatoid arthritis

CRISPRa screen on a genetic risk locus shared by multiple autoimmune diseases identifies a dysfunctional enhancer that affects IRF8 expression through cooperative lncRNA and DNA methylation machinery

Exploring the Bio-Functional Effect of Single Nucleotide Polymorphisms in the Promoter Region of the TNFSF4, CD28, and PDCD1 Genes

GW24-e3853 Identification of Novel Pre-translational Regulatory Mechanisms for NF-kB Activation

Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery

Association of CD40 −1C/T Polymorphism in the 5′-Untranslated Region and Chronic Obstructive Pulmonary Disease

Abstract 568: Identification of Novel Pre-translational Regulatory Mechanisms for NF-?B Activation

SLE Non-Coding Genetic Risk Variant Determines the Epigenetic Dysfunction of an Immune Cell Specific Enhancer That Controls Disease-Critical Microrna Expression

704 Global Identification of Lupus Genetic Risk Variants Modulating the Type I Interferon Pathway Through CRISPR-based Genomic Screening

An autoimmune pleiotropic SNP modulates IRF5 alternative promoter usage through ZBTB3-mediated chromatin looping

The CD40 Gene Polymorphism Rs1883832 is Associated with Risk of Acute Coronary Syndrome in a Chinese Case-Control Study.

Human Genetics in Rheumatoid Arthritis Guides a High-Throughput Drug Screen of the CD40 Signaling Pathway

The CD40 rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels

Mechanisms of Cpg-Induced Cd40 Expression on Murine Bone Marrow-Derived Dendritic Cells

Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis